Who Is 3Chi? A Brand File on the Delta-8 Pioneer

3Chi is one of the most transparent hemp brands we've examined on the questions that decide what's in your body — and one of the least flattering when you look at how it's reviewed as a workplace and a store. That split is the whole story, and it's why a famous pioneer lands at a B rather than an A.

Where it earns its points: it actually manufactures its own products (no mystery white-label partner), in a facility with a verifiable, third-party-audited GMP certification; it posts batch-specific Certificates of Analysis from named, accredited labs; and it's fully traceable to a real founder and a real legal entity. Where it loses them: its Glassdoor and Indeed ratings are poor, its Trustpilot score is mediocre, and — like nearly every hemp brand — it doesn't name the farms its hemp comes from. None of the negatives are safety scandals. They're the ordinary frictions of a company that scaled fast.

The brand "3Chi" is operated by 3C, LLC (its manufacturing arm trades as 3C Labs LLC) — confirmed in the caption of its own federal lawsuit. The founder and CEO is Justin Journay, a public figure who has gone as far as testifying before a state legislative committee on hemp policy. That matters: a real, named, on-the-record founder is a transparency signal that a surprising number of hemp brands can't match.

3Chi describes Journay as a "biochemist with 15 years of product formulation experience" who developed a method to make delta-8 from hemp around 2019. We'll be precise here, because precision is the point: that biographical credential traces to 3Chi's own materials, and we found no independent record (a degree, a prior employer) to verify the specific "biochemist" credential. We're not disputing it — we're flagging that it's company-stated, not independently confirmed. The company is headquartered in the Indianapolis area (Fishers/Carmel, Indiana). Its exact state of incorporation we list as not conclusively verified from a primary filing; we'd rather say that than print a guess.

The single most important question we ask any brand is whether it makes its own product or just slaps a label on someone else's — and whether it'll tell you. Plenty of "brands" are a marketing team reselling a contract manufacturer's gummy. 3Chi is not. It manufactures in-house, in a facility it describes as roughly 112,000 square feet, and says it controls the process "from molecule to final product."

More importantly, that claim is verifiable. 3Chi holds a cGMP certification through CSQ (Cannabis Safety & Quality), and the most recent audit — conducted by a third-party auditor (ASI Food Safety) and benchmarked to the FDA's dietary-supplement and food rules — reportedly scored 98%, with a certificate number on record. A self-proclaimed "GMP facility" is marketing; a third-party-audited certificate you can point to is evidence. This is the gold standard for the manufacturing pillar, and 3Chi clears it. (The company's claim that it's the "only" such facility in its state is a press-release superlative we did not independently verify, and we don't score it.)

Lab testing is where the rubber meets the road for converted cannabinoids like delta-8, which can carry residual solvents or unreacted reagents if made carelessly. 3Chi publishes batch-specific Certificates of Analysis — downloadable PDFs organized by dated batch code — and describes a two-step process: an internal lab plus an ISO-accredited third-party lab. The labs on its COAs are named and real (ACS Laboratory, Avazyme, North Coast Analytical, and others), which is meaningfully better disclosure than the "trust us, it's tested" screenshots many competitors post.

The honest caveat: while 3Chi references "full panel" testing, we could not confirm that every posted COA carries a complete contaminant panel (potency + pesticides + heavy metals + residual solvents + microbials) — some appear potency-focused by filename. So we credit it strongly but not perfectly. On sourcing, 3Chi states its products are made from US hemp, but — like most of the industry — it does not name the specific farms or states on its own pages. That omission costs sourcing points across the board; it isn't unique to 3Chi, but our job is to score what's disclosed.

Readers worry, fairly, about who's quietly bankrolling the companies they buy from. Here's what the record shows for 3Chi: it appears to be privately held and bootstrapped. Crunchbase lists no funding rounds and no outside investors, and a roughly $1.5M expansion was self-funded (tied to publicly reported state job-creation incentives) — a pattern consistent with a founder-owned company that didn't take venture money.

This is where the shine comes off. 3Chi grew fast — to roughly 300–350 employees (as of 2022), concentrated in the Indianapolis area, with public plans to hire hundreds more. That's real US-based operation, and we credit it. But the people who work there don't rate it well: its Glassdoor sits around 1.8/5 (with only about 17% recommending it) and Indeed around 1.9/5. We weight these by review volume so a tiny sample can't swing a score, and even so, these are poor numbers.

We don't have a public breakdown of employees versus contractors, and we found no evidence of overseas labor (operations appear domestic). The takeaway isn't a scandal — it's that a company can be excellent at manufacturing and testing while its own workforce reviews it harshly, and you deserve to see both.

Regulators: we found no FDA warning letter, no recall, and no agency action against 3Chi. This is worth stating plainly because a persistent myth says 3Chi got an FDA delta-8 letter in 2022 — it did not. The 2022 letters went to other companies; one of them was named "Delta 8 Hemp," a name collision that gets misattributed to 3Chi. We flag it precisely so the mistake stops spreading.

Courts: the notable lawsuit involving 3Chi has 3Chi as the plaintiff — it (with industry partners) sued its state's attorney general over whether delta-8 is legal, a policy fight, not misconduct. That case was dismissed in 2025 on jurisdictional grounds. We found no material litigation alleging wrongdoing by the company.

Customers: here the picture is mixed. Its BBB rating is an A (though not BBB-accredited) with relatively few complaints for its size, but its Trustpilot sits around 2.5/5 on a low-but-real volume, with recurring gripes about shipping delays, a shipping fee, and occasional product issues — alongside genuine praise for specific products and for refunds being honored. On Reddit's delta-8 community it's generally regarded as an established, reputable brand rather than a fly-by-night. We average the platforms rather than cherry-pick.

In our view, 3Chi is a brand you can buy from with your eyes open — and that's the highest compliment our method pays, because it means you can actually verify the things that matter. It makes its own product, it has the audited GMP paperwork to back that up, it posts real batch lab results from named labs, and it's run by a named founder with no hidden money behind him. For the core question — "what am I putting in my body, and who actually made it?" — 3Chi answers more completely than most of the industry.

The honest deductions are about everything around the product: it won't tell you which farms grow its hemp, its own employees rate it poorly, and its customer ratings are middling on shipping and service. None of that is a safety red flag; all of it is fair to know before you buy. A solid B, and a good example of why a transparency score isn't the same as a popularity contest. If you want to see how we arrived at every point, the methodology is fully public.